- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 24, 2026 | 396.79M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 395M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 386M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $62M |
| Capex | Q1 2026 · Mar 31, 2025 | $117M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$630M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.04B |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $590M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $590M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.91B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $2.6B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $1.62B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $7.41B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $8.65B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $10.07B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $10.9B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.4B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.99B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.08B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.69B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $5.77B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $6.54B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $11.49B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $12.34B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$3.40 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$2.52 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$3.40 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$2.52 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $173M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $212M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $649M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $856M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.34B |
| Net Income | Q1 2026 · Mar 31, 2025 | −$971M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.39B |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.05B |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $955M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $90M |
| Revenue | Q1 2026 · Mar 31, 2026 | $389M |
| Revenue | Q1 2026 · Mar 31, 2025 | $108M |